Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep644 | Endocrine-related Cancer | ECE2023

Mixed papillary–medullary thyroid carcinoma and cystic adrenal mass

Limniati Christina , Papagianni Eleni , Smarda Magdalini , Kaza Maria , Tsentidis Charalampos

Introduction: Regardless of the fact that the incidence of thyroid cancer has increased significantly in recent years, the simultaneous occurrence of multiple tumors in one thyroid gland is still a rare phenomenon. These tumors have the morphology, either of a single mass with mixed histological features, or of a single lesion consisting of two distinct cell-populations, or of two different tumors between which normal thyroid tissue is interposed. Various theories have been pr...

ea0049ep38 | Adrenal cortex (to include Cushing's) | ECE2017

Metabolic syndrome is common among patients with adrenal incidentalomas, but not associated with functional adrenal status

Tsentidis Charalampos , Bampilis Andreas , Ntova Vasiliki , Betsi Grigoria , Kassi Georgia

Background: Adrenal incidentalomas (AI) have an increasing prevalence during last decades, probably due to the extended use of new imaging techniques and longer life expectancy. Adrenal hormonal hypersecretion, even subclinical, is probably related to cardiovascular disease (CVD).Methods: We evaluated 100 patients with adrenal masses, incidentally discovered in imaging techniques performed for non adrenal disorders (67 Female, 33 Male, mean 58.1±12....

ea0090ep93 | Adrenal and Cardiovascular Endocrinology | ECE2023

Adrenal Venous Sampling in a patient with bilateral adrenal adenomas and Cushing’s syndrome

Limniati Christina , Nikolaou Vasileios , Georgiadou Magdalini , Vellios Maria , Moustaka Aikaterini , Rizopoulou Parthena , Tsentidis Charalampos

Introduction: Adrenal Cushing’s syndrome accounts for 15-20% of all the causes of endogenous hypercortisolism, mainly due to unilateral adenomas and adrenal cancer. Approximately 9-17% of patients with ACTH-independent Cushing’s syndrome have bilateral adrenal adenomas. Subsequently, their management is quite demanding. The main difficulty lies in distinguishing between a functional and a non-functional adrenal mass, since this cannot be reliably achieved by routine ...

ea0063p578 | Diabetes, Obesity and Metabolism 2 | ECE2019

Factors affecting effective gestational diabetes mellitus management: six-year experience from a single tertiary center

Tsentidis Charalampos , Mitakidou Eleni , Bampilis Andreas , Fragkos Dimitrios , Panos Christos , Limniati Christina , Kassi Georgia

Introduction: Effective gestational diabetes mellitus (GDM) management is pivotal for reducing delivery complications for both mother and offspring, since a linear and continuous association between blood glucose and unfavorable outcomes has been extensively reported. The aim of present study was to investigate possible factors affecting GDM treatment goals.Methods: We retrospectively evaluated 136 consecutive patients with GDM, treated in our department...

ea0063p687 | Pituitary and Neuroendocrinology 2 | ECE2019

Patient compliance, mainly due to lower socioeconomic status, is the principal predictor of effective acromegaly treatment: data from a single tertiary center

Tsentidis Charalampos , Bampilis Andreas , Fragkos Dimitrios , Panos Christos , Mitakidou Eleni , Limniati Christina , Kassi Georgia

Introduction: Effective acromegaly treatment in the era of somatostatin analog therapy may initially seem easy to apply. Several factors, modifiable or not, may be involved in every patient’s treatment. The aim of this study was to evaluate possible factors affecting effective acromegaly treatment.Methods: From the original pool of 25 patients, that were diagnosed with acromegaly in our department during the last 15 years, 18 are currently being fol...

ea0049gp99 | Diabetes therapy & complications 1 | ECE2017

Higher levels of adiponectin might contribute to lower bone mass observed in patients with type 1 diabetes, through alterations in osteocalcin energy circuit signaling of bone cells.

Tsentidis Charalampos , Gourgiotis Dimitrios , Kossiva Lydia , Doulgeraki Artemis , Marmarinos Antonios , Karavanaki Kyriaki

Introduction: Recent advances in energy homeostasis revealed a significant interconnection between bone and adipose tissue through osteocalcin. Reduced bone mass documented in type 1 diabetes mellitus (T1D) could be related to disregulation of adipokine signaling on bone.Materials and Methods: We evaluated 40 children and adolescents with T1D (mean±S.D. age 13.04±3.53 years, mean±S.D. T1D duration 5.15±3....

ea0049ep1008 | Pituitary - Clinical | ECE2017

Autoimmune hypophysitis with isolated corticotroph cell destruction due to Pembrolizumab treatment in a female patient with metastatic melanoma

Vasileiou Emmanouil , Tsentidis Charalampos , Bampilis Andreas , Ntova Vasiliki , Betsi Grigoria , Kassi Georgia

Introduction: Pembrolizumab is a programmed death receptor-1(PD-1)-blocking antibody, used in a variety of advanced malignant tumors with promising results, although adverse events are not rare.Case report: We present the case of an adult female, with negative personal and family history of autoimmune diseases, who developed malignant superficial melanoma of right wrist 6 years ago. She was initially treated with surgical resection (lesion and ipsilatera...

ea0037gp.12.06 | Diabetes and obesity – Translational diabetes | ECE2015

Increased levels of Dickkopf-1 may indicate lower osteoblast signaling, predisposing to lower bone mineral density in children and adolescents with type 1 diabetes mellitus

Tsentidis Charalampos , Gourgiotis Dimitrios , Kossiva Lydia , Marmarinos Antonios , Doulgeraki Artemis , Karavanaki Kyriaki

Introduction: T1DM is a risk factor for reduced bone mass, disrupting several bone metabolic pathways. Dickkopf-1 is an inhibitor of the Wnt/b-catenin bone metabolic pathway. Increased fracture risk and elevated Dickkopf-1 levels have been documented in adult patients with T2DM. No relevant data exist on childhood T1DM. Our aim was to study plasma Dickkopf-1 concentration in children and adolescents with T1DM and controls and to correlate Dickkopf-1 levels with metabolic bone ...

ea0035p288 | Clinical case reports Thyroid/Others | ECE2014

Primary hyperparathyroidism due to ectopic mediastinal parathyroid gland at the level of anterior wall of ascending aorta

Gogali Foteini , Tzatzadakis Nikolaos , Proikaki Stella , Samartzis Georgios , Prokovas Ioannis , Tsentidis Charalampos

Introduction: Parathyroid adenoma is the most common cause of primary hyperparathyroidism (PHPT) resulting in hypercalcemia and hypercalciuria due to autonomous secretion of PTH. Ectopic parathyroid adenoma, as a consequence of variability in the glandular tissue migration during the embryologic life or a supernumary fifth parathyroid gland, has an incidence of 25% among patients with PHPT. The incidence of deeply mediastinal ectopic parathyroid adenoma is 1–3%.<p cla...

ea0035p427 | Diabetes complications | ECE2014

Sclerostin distribution in children and adolescents with type 1 diabetes mellitus and correlation with bone metabolism markers and bone mineral density

Tsentidis Charalampos , Gourgiotis Dimitrios , Kossiva Lydia , Marmarinos Antonios , Doulgeraki Artemis , Karavanaki Kyriaki

Introduction: Sclerostin is an inhibitor of the Wnt/β-catenin bone metabolic pathway. Increased sclerostin levels and reduced bone mineral density (BMD) have been documented in adult patients with diabetes mellitus (DM), predominantly in those with type 2 diabetes mellitus (T2DM). No relevant data exist on childhood T1DM. Our aim was to study plasma sclerostin concentration in children and adolescents with T1DM and controls and to correlate sclerostin levels with metaboli...